# Amphotericin B Suspension in Refractory Chronic Sinusitis

> **NCT00425620** · PHASE3 · COMPLETED · sponsor: **Accentia Biopharmaceuticals** · enrollment: 300 (actual)

## Conditions studied

- Chronic Sinusitis

## Interventions

- **DRUG:** SinuNase

## Key facts

- **NCT ID:** NCT00425620
- **Lead sponsor:** Accentia Biopharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** —
- **Final completion:** 2007-10
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2007-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00425620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00425620, "Amphotericin B Suspension in Refractory Chronic Sinusitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00425620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*